Raymond W. Cohen, Director at KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS), bought 10,000 shares at $19.98 ($200K) on 2026-03-26, disclosed to the SEC on 2026-03-30.
Open-market purchase of $200k KMTS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| AXNX | SELL | 2023-02-02 | $3.8M | — | Filing → |
| AXNX | SELL | 2023-01-18 | $5.4M | — | Filing → |
| AXNX | SELL | 2022-08-10 | $4.9M | — | Filing → |